Ceramide synthase 5 and S1P lyase were upregulated, while glucosylceramidase and UDP-galactose ceramide galactosyltransferase were downregulated in SLE patients compared to controls [20]. This evidence concerns the gene CERS5 and systemic lupus erythematosus.